224 related articles for article (PubMed ID: 23836153)
1. MED12 mutations in human diseases.
Wang H; Shen Q; Ye LH; Ye J
Protein Cell; 2013 Sep; 4(9):643-6. PubMed ID: 23836153
[TBL] [Abstract][Full Text] [Related]
2. MED12 related disorders.
Graham JM; Schwartz CE
Am J Med Genet A; 2013 Nov; 161A(11):2734-40. PubMed ID: 24123922
[TBL] [Abstract][Full Text] [Related]
3. MED12 missense mutation in a three-generation family. Clinical characterization of MED12-related disorders and literature review.
Rubinato E; Rondeau S; Giuliano F; Kossorotoff M; Parodi M; Gherbi S; Steffan J; Jonard L; Marlin S
Eur J Med Genet; 2020 Mar; 63(3):103768. PubMed ID: 31536828
[TBL] [Abstract][Full Text] [Related]
4. A novel variant in MED12 gene: Further delineation of phenotype.
Narayanan DL; Phadke SR
Am J Med Genet A; 2017 Aug; 173(8):2257-2260. PubMed ID: 28544239
[TBL] [Abstract][Full Text] [Related]
5.
Plassche SV; Brouwer AP
Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33925166
[TBL] [Abstract][Full Text] [Related]
6. Clinical and neurocognitive characterization of a family with a novel MED12 gene frameshift mutation.
Lesca G; Moizard MP; Bussy G; Boggio D; Hu H; Haas SA; Ropers HH; Kalscheuer VM; Des Portes V; Labalme A; Sanlaville D; Edery P; Raynaud M; Lespinasse J
Am J Med Genet A; 2013 Dec; 161A(12):3063-71. PubMed ID: 24039113
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation in MED12 causes FG syndrome (Opitz-Kaveggia syndrome).
Rump P; Niessen RC; Verbruggen KT; Brouwer OF; de Raad M; Hordijk R
Clin Genet; 2011 Feb; 79(2):183-8. PubMed ID: 20507344
[TBL] [Abstract][Full Text] [Related]
8. FG syndrome: the FGS2 locus revisited.
Perche O; Laudier B; Menuet A; Odent S; Laumonnier F; Briault S
Am J Med Genet A; 2012 Jun; 158A(6):1489-92. PubMed ID: 22528511
[No Abstract] [Full Text] [Related]
9. Behavioral features in young adults with FG syndrome (Opitz-Kaveggia syndrome).
Graham JM; Clark RD; Moeschler JB; Rogers RC
Am J Med Genet C Semin Med Genet; 2010 Nov; 154C(4):477-85. PubMed ID: 20981778
[TBL] [Abstract][Full Text] [Related]
10. The FG syndrome from a pathological perspective.
Neri C; Moser K; Pysher TJ; Boettger DR; Neri G; Opitz JM
Fetal Pediatr Pathol; 2011; 30(2):71-6. PubMed ID: 21391746
[TBL] [Abstract][Full Text] [Related]
11. Activating RNAs associate with Mediator to enhance chromatin architecture and transcription.
Lai F; Orom UA; Cesaroni M; Beringer M; Taatjes DJ; Blobel GA; Shiekhattar R
Nature; 2013 Feb; 494(7438):497-501. PubMed ID: 23417068
[TBL] [Abstract][Full Text] [Related]
12. Somatic MED12 mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms.
Kämpjärvi K; Kim NH; Keskitalo S; Clark AD; von Nandelstadh P; Turunen M; Heikkinen T; Park MJ; Mäkinen N; Kivinummi K; Lintula S; Hotakainen K; Nevanlinna H; Hokland P; Böhling T; Bützow R; Böhm J; Mecklin JP; Järvinen H; Kontro M; Visakorpi T; Taipale J; Varjosalo M; Boyer TG; Vahteristo P
Prostate; 2016 Jan; 76(1):22-31. PubMed ID: 26383637
[TBL] [Abstract][Full Text] [Related]
13. Dysregulations of sonic hedgehog signaling in MED12-related X-linked intellectual disability disorders.
Srivastava S; Niranjan T; May MM; Tarpey P; Allen W; Hackett A; Jouk PS; Raymond L; Briault S; Skinner C; Toutain A; Gecz J; Heath W; Stevenson RE; Schwartz CE; Wang T
Mol Genet Genomic Med; 2019 Apr; 7(4):e00569. PubMed ID: 30729724
[TBL] [Abstract][Full Text] [Related]
14. Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas.
Kämpjärvi K; Park MJ; Mehine M; Kim NH; Clark AD; Bützow R; Böhling T; Böhm J; Mecklin JP; Järvinen H; Tomlinson IP; van der Spuy ZM; Sjöberg J; Boyer TG; Vahteristo P
Hum Mutat; 2014 Sep; 35(9):1136-41. PubMed ID: 24980722
[TBL] [Abstract][Full Text] [Related]
15. Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity.
Turunen M; Spaeth JM; Keskitalo S; Park MJ; Kivioja T; Clark AD; Mäkinen N; Gao F; Palin K; Nurkkala H; Vähärautio A; Aavikko M; Kämpjärvi K; Vahteristo P; Kim CA; Aaltonen LA; Varjosalo M; Taipale J; Boyer TG
Cell Rep; 2014 May; 7(3):654-60. PubMed ID: 24746821
[TBL] [Abstract][Full Text] [Related]
16. MED12 exon 2 mutations in histopathological uterine leiomyoma variants.
Mäkinen N; Vahteristo P; Kämpjärvi K; Arola J; Bützow R; Aaltonen LA
Eur J Hum Genet; 2013 Nov; 21(11):1300-3. PubMed ID: 23443020
[TBL] [Abstract][Full Text] [Related]
17. MED12 and uterine smooth muscle oncogenesis: State of the art and perspectives.
Croce S; Chibon F
Eur J Cancer; 2015 Aug; 51(12):1603-10. PubMed ID: 26037152
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours.
Matsubara A; Sekine S; Yoshida M; Yoshida A; Taniguchi H; Kushima R; Tsuda H; Kanai Y
Histopathology; 2013 Mar; 62(4):657-61. PubMed ID: 23347103
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors.
Je EM; Kim MR; Min KO; Yoo NJ; Lee SH
Int J Cancer; 2012 Sep; 131(6):E1044-7. PubMed ID: 22532225
[TBL] [Abstract][Full Text] [Related]
20. MED12 mutation frequency in unselected sporadic uterine leiomyomas.
Heinonen HR; Sarvilinna NS; Sjöberg J; Kämpjärvi K; Pitkänen E; Vahteristo P; Mäkinen N; Aaltonen LA
Fertil Steril; 2014 Oct; 102(4):1137-42. PubMed ID: 25108465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
